Psychopharmacologic treatment of children prenatally exposed to drugs of abuse

Human Psychopharmacology
Leslie A HulvershornChristopher J McDougle

Abstract

This pilot study compared the pharmacologic treatment history and clinical outcomes observed in pediatric outpatients with psychiatric disorders exposed to drugs of abuse in utero to those of an age-matched, sex-matched and psychiatric disorder-matched, non-drug-exposed group. In this matched cohort study, medical records of children treated at an academic, child and adolescent psychiatry outpatient clinic were reviewed. Children with caregiver-reported history of prenatal drug exposure were compared with a non-drug-exposed control group being cared for by the same providers. Patients were rated with the Clinical Global Impressions-Severity scale (CGI-S) throughout treatment. The changes in pre-treatment and post-treatment CGI-S scores and the total number of medication trials were determined between groups. The drug-exposed group (n = 30) had a higher total number of lifetime medication trials compared with the non-drug-exposed group (n = 28) and were taking significantly more total medications, at their final assessment. Unlike the non-drug-exposed group, the drug-exposed group demonstrated a lack of clinical improvement. These results suggest that in utero drug-exposed children may be more treatment-refractory to or experien...Continue Reading

References

Jan 1, 1992·Child Abuse & Neglect·S J Kelley
Dec 1, 1993·Child Development·S W JacobsonJ W Ager
Mar 10, 1999·Journal of Clinical Child Psychology·G GoodmanS M Cox
Jun 15, 2001·The Journal of Comparative Neurology·M S Lidow, Z M Song
Feb 28, 2002·Child Abuse & Neglect·Brenda D Smith, Mark F Test
Sep 5, 2002·Forensic Science International : Synergy·Marilyn A Huestis, Robin E Choo
Dec 11, 2003·Obstetrics and Gynecology Clinics of North America·Dace S Svikis, Kathryn Reid-Quiñones
Jan 27, 2004·Brain Research. Developmental Brain Research·C J Malanga, Barry E Kosofsky
Aug 19, 2004·Neurotoxicology and Teratology·Barbara A LewisMeeyoung O Min
Jul 26, 2005·Neurotoxicology and Teratology·Lyvia M V CarneiroGlauce S B Viana
Jul 13, 2006·Neurotoxicology and Teratology·Diana L Dow-EdwardsL R Stanford
Sep 7, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Anne BartuDorota A Doherty
Sep 12, 2006·European Child & Adolescent Psychiatry·Hans-Christoph SteinhausenChrista Winkler Metzke
Jan 4, 2007·European Child & Adolescent Psychiatry·Justin H G Williams, Louise Ross
May 27, 2008·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Prasanna NairVirginia A Keane
Nov 26, 2011·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·Tina Birk Irner
Jul 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Margaret A SheridanCharles A Nelson
Oct 9, 2012·Social Work·Elizabeth C Pomeroy, Lori Holleran Steiker
Jun 1, 1998·Annals of the New York Academy of Sciences·Eitan Friedman, Hoau-Yan Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.